Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.

Gastroenterology - 1 Jul 2009

Wasmuth Hermann E, Lammert Frank, Zaldivar Mirko Moreno, Weiskirchen Ralf, Hellerbrand Claus, Scholten David, Berres Marie-Luise, Zimmermann Henning, Streetz Konrad L, Tacke Frank, Hillebrandt Sonja, Schmitz Petra, Keppeler Hildegard, Berg Thomas, Dahl Edgar, Gassler Nikolaus, Friedman Scott L, Trautwein Christian

Abstract excerpt

BACKGROUND & AIMS: Fibrosis is the hallmark of chronic liver diseases, yet many aspects of its mechanism remain to be defined. Chemokines are ubiquitous chemotactic molecules that mediate many acute and chronic inflammatory conditions, and CXC chemokine genes colocalize with a locus previously shown to include fibrogenic genes. We investigated the roles of the chemokine CXCL9 and its receptor CXCR3 in liver...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carbon Tetrachloride
Share to Collagen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatic Stellate Cells

Share to Hepatitis C, Chronic

Share to Interferon-gamma

Share to Liver Cirrhosis

Share to Receptors, CXCR3

Share to Th1 Cells

Source

Open in PubMed Open full text

Identifiers

PMID: 19344719
DOI: 10.1053/j.gastro.2009.03.053
PMCID: PMC2892869

Genes

CXCL9
CXCR3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.PMID 19344719Read ↗

Potential therapeutic manipulations of the CXCR3 chemokine axis for the treatment of inflammatory fibrosing diseasesSemantic proximity Read ↗

Chemokine CXCL14 acts as a potential genetic target for liver fibrosisSemantic proximity Read ↗

Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C.Semantic proximity Read ↗

The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection.Semantic proximity Read ↗

Chemokines in liver inflammation and fibrosis.Semantic proximity Read ↗

The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C.Semantic proximity Read ↗

Study of CXCL9-11 gene polymorphisms in liver fibrosis among patients with chronic hepatitis C.Semantic proximity Read ↗

CXCL9 and CXCL13 as Predictive Biomarkers for Autoimmune-like Phenotype in Chronic Hepatitis C: Evidence for Viral-Induced Autoimmune Hepatitis TransitionSemantic proximity Read ↗

Emerging Importance of Chemokine Receptor CXCR4 and Its Ligand in Liver DiseaseSemantic proximity Read ↗

The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection.Semantic proximity Read ↗

Direct, Interferon-Independent Activation of the CXCL10 Promoter by NF-κB and Interferon Regulatory Factor 3 during Hepatitis C Virus InfectionSemantic proximity Read ↗

Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.